Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.20
19.12.20
€72.00
19.12.21
25.15%
01.09.21

paarvani 
19.12.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.01
18.12.20
€34.00
18.12.21
-5.35%
15.03.21

Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Snowman 
18.12.20 80%
sell
Pfizer Inc.

Start price
Target price
Perf. (%)
€30.91
17.12.20
€29.00
-1.81%
21.12.20

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Traumtanz 
17.12.20 50%
sell
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€65.60
16.12.20
-
16.12.21
-5.49%
23.02.21

Midas 
16.12.20 50%
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€273.65
16.12.20
-
16.12.21
-0.75%
23.02.21

Shooter 
16.12.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€32.45
14.12.20
€36.00
14.12.21
22.97%
04.11.21

hbvv9498 
14.12.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€35.01
12.12.20
-
12.12.21
-14.23%
24.03.21

Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
FXX 
12.12.20 50%
sell
Johnson & Johnson

Start price
Target price
Perf. (%)
€125.64
11.12.20
-
11.12.21
0.60%
11.12.20

Sievi 
11.12.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€35.24
08.12.20
-
08.12.21
-2.57%
14.12.20

phonebroker 
08.12.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€33.48
07.12.20
€36.50
07.12.21
9.98%
11.10.21

Thommy123 
07.12.20 50%
sell
Pfizer Inc.

Start price
Target price
Perf. (%)
€32.80
04.12.20
-
7.42%
08.12.20

phonebroker 
04.12.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.50
30.11.20
€38.00
30.11.21
18.40%
02.08.21

Could be worthwhile Investment >10% per year
Very high dividend yield expected
Fair valuation
Higher EBIT margin than peer group
cbetz100 
30.11.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.50
30.11.20
-
30.11.21
14.62%
20.10.21

anthonyefs 
30.11.20 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€120.86
30.11.20
€150.00
30.11.21
20.54%
01.08.21

bkellerm82 
30.11.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€30.50
25.11.20
-
25.11.21
46.89%
26.11.21

Karolosagious 
25.11.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.30
21.11.20
€40.00
21.11.21
45.99%
22.11.21

marge 
21.11.20 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€123.90
21.11.20
€140.00
2.62%
10.12.20

High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Traumtanz 
21.11.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.40
18.11.20
-
18.11.21
45.06%
19.11.21

EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Low dividend yield expected
shadow 
18.11.20 50%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€70.00
18.11.20
€82.00
18.11.21
-10.59%
12.09.21

Jonny5 
18.11.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.31
16.11.20
-
5.61%
11.12.20

FinanceClub_UoM 
16.11.20 50%
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€296.90
12.11.20
€400.00
12.11.21
35.67%
13.11.21

SolidInvest 
12.11.20 50%
sell
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.02
12.11.20
-
12.11.21
41.63%
13.11.21

Rick_NRW 
12.11.20 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€124.74
12.11.20
-
12.11.21
14.67%
13.11.21

Rick_NRW 
12.11.20 50%
sell
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€68.60
10.11.20
€50.00
10.11.21
6.87%
11.11.21

Rambo 
10.11.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€33.30
09.11.20
€37.95
-11.94%
17.12.20

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Traumtanz 
09.11.20 50%